Loading...
Symbols:
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Transcripts
- Pacific Sunwear F3Q08 (Qtr End 11/1/08) Earnings Call Transcript
- Mad Catz Interactive, Inc. F2Q09 (Qtr End 09/30/2008) Earnings Call Transcript
- Provectus Pharmaceuticals, Inc. The Wall Street Analyst Forum Call Transcript
- Point Blank Solutions, Inc. Q3 2008 (Quarter End 9/30/08) Earnings Call Transcript
- Navios Maritime Holdings Inc., Q3 2008 Earnings Call Transcript
- Gran Tierra Energy Inc. Q3 2008 (Qtr End 09/30/08) Earnings Call Transcript
- Oxygen Biotherapeutics, Inc. The Wall Street Analyst Forum Call Transcript
- ArvinMeritor, Inc. F4Q08 (Quarter End 9/28/08) Earnings Call Transcript
- Saks Incorporated Q3 2008 (Qtr End 11/01/08) Earnings Call Transcript
- Omega Navigation Enterprises, Inc. Q3 2008 Earnings Call Transcript
-
Editors' Picks
-
Most Popular
- GM Could Benefit from Bankruptcy
- Throwing in the Towel on This Market?
- General Electric: Genuine Risk of Collapse?
- Food: Against Self-Sufficiency
- The Fed: Now the World's Largest Private Bank
- Key to the Global Equity Market: Trend and Cycle Analysis of U.S. Retail
- Full list of Editors' Picks »
- General Electric: Genuine Risk of Collapse? »
- Should We Really Bail Out the Big Three Automakers with $73.20 Per Hour Labor? »
- Memo to Warren: AmEx Preferred at 15%, Warrants at $12 »
- Jim Rogers on China »
- Peak Oil's Bell Is Ringing »
- UltraShort ETFs: At a Tipping Point? »
- The Pickens Plan Changes Its Strategy »
- The Biggest Problem Detroit's Big Three Face »
- Tech May Be a Wreck, But This Isn't 2001 »
- 11 Stocks Selling Below Cash »
- Wall Street Breakfast: Must-Know News »
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
Timoth J. Roe, MD, MBA
1 Comment
American Oriental Bioengineering: Underwhelming Q3 Earnings
AOB's report was solid, and with compared to the reports of several other US traded China pharmas this quarter, they may end up being one of the best of the bunch.
In my opinion, the level of expectations was too high. They had a big run from the summer lows, and share price was right at their historic high prior to the report. The key tell was the 2.2% rally on the day of the report. For AOB to break through to a new high under those conditions they needed to beat on all metrics and raise guidance.
Despite these short term factors, the company is doing a good executing well on its business model. Maintaining guidance for this quarter despite strong performance may well be a smart strategic move. Next quarter should be seasonally strong, and if the acquisitions can be fully integrated quickly there should be an additional boost to both top and bottom lines.
This may position the company for a better earnings beat next quarter. I always like companies that underpromise and overdeliver. With a little share price backing and filling near the old high, this company looks good for next quarter.